OptiTROP-Lung01

Phase 2 study OptiTROP-Lung01 had promising results in patients with advanced NSCLC – LUNGevity Foundation

LUNGevity Foundation shared on X/Twitter:

“Phase 2 study (OptiTROP-Lung01) had promising results in patients with advanced NSCLC . Phase 3 study versus immunotherapy is underway. More ADC studies are needed.”

Image

Source: LUNGevity Foundation/X

ADC advanced NSCLC cancer immunotherapy LUNGevity Foundation OncoDaily Oncology OptiTROP-Lung01 phase 2 study Phase 3